Discussion
Publisher
Springer Singapore
Reference35 articles.
1. Vitiello, M., A. Zullo, L. Servillo, F.P. Mancini, A. Borriello, A. Giovane, F. Della Ragione, N. D’Onofrio, and M.L. Balestrieri. 2016. Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. Ageing Research Review. 2. Tasselli, L., W. Zheng, and K.F. Chua. 2016. SIRT6: Novel Mechanisms and Links to Aging and Disease. Trends in Endocrinology and Metabolism 28: 168–185. 3. Parenti, M.D., A. Grozio, I. Bauer, L. Galeno, P. Damonte, E. Millo, G. Sociali, C. Franceschi, A. Ballestrero, S. Bruzzone, A. Del Rio, and A. Nencioni. 2014. Discovery of novel and selective SIRT6 inhibitors. Journal of Medicinal Chemistry 57: 4796–4804. 4. Feldman, J.L., J. Baeza, and J.M. Denu. 2013. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. Journal of Biological Chemistry 288: 31350–31356. 5. Beauharnois, J.M., B.E. Bolivar, and J.T. Welch. 2013. Sirtuin 6: a review of biological effects and potential therapeutic properties. Molecular BioSystems 9: 1789–1806.
|
|